The clinical phenotype of Noonan syndrome

Monographs in Human Genetics

Volumn 17, Issue , 2009, Pages 9-19

  Allanson, J E ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870192885     PISSN: 00770876     EISSN: 16623835     Source Type: Book Series    
DOI: 10.1159/000160047     Document Type: Article

References (137)

1. Noonan JA, Ehmke DA: Associated noncardiac malformations in children with congenital heart disease. J Pediatr 1963;63:468-470.
2. Kobylinski O: Über eine flughautähnliche Ausbreitung am Halse. Arch Anthropol 1883;14:342-348.
3. Mendez H M M, Opitz JM: Noonan syndrome: A review. Am J Med Genet 1985;21:493-506. (Pubitemid 15051173)
4. Sharland M, Burch M, McKenna WM, Patton MA: A clinical study of Noonan syndrome. Arch Dis Child 1992;67:178-183.
5. Shaw AC, Kalidas K, Crosby AH, Jeffrey S, Patton MA: The natural history of Noonan syndrome: a long-term followup study. Arch Dis Child 2007;92; 128-132.
6. Allanson JE: Noonan syndrome. J Med Genet 1987;24:9-13. (Pubitemid 17228867)
7. Char FC, Rodriguez-Fernandez HL, Scott CI, Borgankoar DS, Bell BB, Rowe RD: The Noonan-syndrome: A clinical study of forty-five cases. Birth Defects 1972;8:110-118.
8. Noonan JA: Noonan syndrome: Update and review for the primary pediatrician. Clin Pediatr 1994;33:548-555. (Pubitemid 24286203)
9. Yoshida R, Hasegawa T, Hasegawa Y, Nagai T, Kinoshita E, et al: Proteintyrosine phosphatase, non-receptor type 11 mutation analysis and clinical assessment in 45 patients with Noonan syndrome. J Clin Endocrinol Metab 2004;89:3359-3364. (Pubitemid 38951904)
10. Allanson JE: Time and natural history: the changing face. J Craniofac Genet Dev Biol 1989;9:21-28. (Pubitemid 19153173)
11. Allanson JE, Hall JG, Hughes HE, Preus M, Witt RD: Noonan syndrome: the changing phenotype. Am J Med Genet 1985;21:507-514. (Pubitemid 15051174)
12. Allanson JE: Noonan syndrome: the changing face. Proc Greenwood Genet Ctr 2001;20:78-79.
13. Noonan JA, O'Connor W: Noonan syndrome: A clinical description emphasizing the cardiac findings. Acta Paediatr Jpn 1996;38:76-83. (Pubitemid 26123034)
14. Burch M, Sharland M, Shinebourne E, Smith G, Patton M, McKenna W: Cardiologic abnormalities in Noonan syndrome: Phenotypic diagnosis and echocardiographic assessment of 118 patients. J Am Coll Cardiol 1993;22:189-192.
15. Digilio MC, Marino B, Giannotti A, Dallapiccola B: Noonan syndrome with cardiac left-sided obstructive lesions. Hum Genet 1997;99:289.
16. Digilio MC, Marino B, Giannotti A, Dallapiccolo B: Exclusion of 22q11 deletion in Noonan syndrome with tetralogy of Fallot. Am J Med Genet 1996;62:413-414.
17. Digilio MC, Marino B, Picchio F, Prandstraller D, Toscana A, et al: Noonan syndrome and aortic coarctation. Am J Med Genet 1998;80:160-162. (Pubitemid 28485697)
18. Ishizawa A, Oho S-I, Dodo H, Katori T, Homma S-I: Cardiovascular abnormalities in Noonan syndrome: the clinical findings and treatments. Acta Paediatr Jpn 1996;38:84-90. (Pubitemid 26123035)
19. Marino B, Digilio MC, Toscana A, Giannotti A, Dallapiccola B: Noonan syndrome: structural abnormalities of the mitral valve causing subaortic obstruction. Eur J Pediatr 1995;154:949-952.
20. Ishikawa Y, Sekiguchi K, Akasaka Y, Ito K, Akishima Y, et al: Fibromuscular dysplasia of coronary arteries resulting in myocardial infarction associated with hypertrophic cardiomyopathy in Noonan's syndrome. Hum Pathol 2003;34:282-284. (Pubitemid 36356682)
21. Purnell R, Williams I, Von Oppell U, Wood A: Giant aneurysms of the sinuses of Valsalva and aortic regurgitation in a patient with Noonan's syndrome. Eur J Cardiothorac Surg 2005;28:346-348. (Pubitemid 41020720)
22. Burch M, Mann JM, Sharland M, Shinebourne EA, Patton MA, McKenna WJ: Myocardial disarray in Noonan syndrome. Br Heart J 1992;68:586-588. (Pubitemid 23001736)
23. Nishikawa T, Ishiyama S, Shimojo T, Takeda K, Kasjima T, Momma K: Hypertrophic cardiomyopathy in Noonan syndrome. Acta Paediatr Jpn 1996;38:91-98. (Pubitemid 26123036)
24. Shimizu A, Oku Y, Matsuo K, Hashiba K: Hypertrophic cardiomyopathy progressing to a dilated cardiomyopathylike feature in Noonan's syndrome. Am Heart J 1992;123:814-816.
25. Wilmshurst PT, Katritsis D: Restrictive and hypertrophic cardiomyopathies in Noonan syndrome: the overlap syndromes. Heart 1996;75:94-97. (Pubitemid 26058462)
26. Yu CM, Chow LT, Sanderson JE: Dilated cardiomyopathy in Noonan's syndrome. Int J Cardiol 1996;56:83-85. (Pubitemid 26313315)
27. Noonan JA: Noonan syndrome; in Goldstein S, Reynolds CR (eds): Handbook of Neurodevelopmental and Genetic Disorders in Adults. New York, Guilford Press, 2005, pp 308-319.
28. Shah N, Rodriguez M, St Louis D, Lindley K, Milla PJ: Feeding difficulties and foregut dysmotility in Noonan syndrome. Arch Dis Child 1999;81:28-31. (Pubitemid 29307452)
29. Ranke MB, Heidemann P, Knupfer C, Enders H, Schmaltz AA, Bierich JR: Noonan syndrome: growth and clinical manifestations in 144 cases. Eur J Pediatr 1988;148:220-227. (Pubitemid 19016143)
30. Witt DR, Keena B, Hall JG, Allanson JE: Growth curves for height in Noonan's syndrome. Clin Genet 1986;30:150-153. (Pubitemid 16004743)
31. Noordam C, Van der Burgt I, Sweep CG, Delemarre-Van De Waal HA, Sengers RC, Otten BJ: Growth hormone (GH) secretion in children with Noonan syndrome: frequently abnormal without consequences for growth or GH treatment. Clin Endocrinol 2001;54:53-59. (Pubitemid 32158705)
32. Noordam K, Van der Burgt I, Brunner HG, Otten BJ: The relationship between clinical severity of Noonan's syndrome and growth, growth hormone (GH) secretion and response to GH. J Pediatr Endocrinol Metab 2002;15:175-180. (Pubitemid 34704791)
33. Binder G, Neuer K, Ranke MB, Wittekindt NE: PTPN11 mutations are associated with mild GH resistance in individuals with Noonan syndrome. J Clin Endocrinol Metab 2005;90:5377-5381. (Pubitemid 41262304)
34. Ahmed ML, Foot AB, Edge JA, Lamkin VA, Savage MO, Dunger DB: Noonan's syndrome: Abnormalities of the growth hormone IGF-1 axis and the response to treatment with human biosynthetic growth hormone. Acta Paediatr Scand 1991;80:446-450.
35. MacFarlane CE, Brown DC, Johnston LB, Patton MA, Dunger DB, et al: Growth hormone therapy and growth in children with Noonan's syndrome: Results of 3 years' follow-up. J Clin Endocrinol Metab 2001;86:1953-1956. (Pubitemid 32472903)
36. Raaijmakers R, Noordam C, K'aragiannis G, Gregory JW, Hertel NT, Sipila I, Otten BJ: Response to growth hormone treatment and final height in Noonan syndrome in a large cohort of patients in the KIGS database. J Pediatr Endocrinol Metab 2008;21:267-273. (Pubitemid 351559864)
37. Ogawa M, Moriya N, Ikeda H, Tanae A, Tanaka T, et al: Clinical evaluation of recombinant human growth hormone in Noonan syndrome. Endocr J 2004;51:61-68. (Pubitemid 38405146)
38. Thomas BC, Stanhope R: Long-term treatment with growth hormone in Noonan's syndrome. Acta Paediatr 1993;82:853-855. (Pubitemid 23291859)
39. Kelnar C J H: Growth hormone therapy in Noonan syndrome. Horm Res 2000;53(Suppl 1):77-81. (Pubitemid 30481325)
40. Osio D, Dahlgren J, Wikland KA, Westphal O: Improved final height with long-term growth hormone treatment in Noonan syndrome. Acta Pediatr 2005;94:1232-1237. (Pubitemid 41510618)
41. Ferreira LV, Souza SA, Arnhold IJ, Mendonca BB, Jorge AA: PTPN11 (protein tyrosine phosphatase nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome. J Clin Endocrinol Metab 2005;90:5156-5160. (Pubitemid 41262268)
42. Limal J-M, Parfait B, Cabrol S, Bonnet D, Leheup B, et al: Noonan syndrome: Relationships between genotype, growth, and growth factors. J Clin Endocrinol Metab 2005;91:300-306.
43. Stofega MR, Herrington J, Billestrup N, Carter-Su C: Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B. Mol Endocrinol 2000;14:1338-1350.
44. Money J, Kalus ME: Noonan's syndrome: IQ and specific disabilities. Am J Dis Child 1979;133:846-850.
45. Lee DA, Portnoy S, Hill P, Gillberg C, Patton MA: Psychological profile of children with Noonan syndrome. Dev Med Child Neurol 2005;47:35-38.
46. Cornish KM: Verbal-performance discrepancies in a family with Noonan syndrome. Am J Med Genet 1996;66:235-236. (Pubitemid 27002957)
47. Sarimski K: Developmental and behavioural phenotype in Noonan syndrome. Genet Couns 2000;11:383-390. (Pubitemid 32002561)
48. Van der Burgt I, Thoone G, Roosenboom N, Assman-Hulsman C, Gabreels F, et al: Patterns of cognitive functioning in school-aged children with Noonan syndrome associated with variability of phenotypic expression. J Pediatr 1999;135:707-713. (Pubitemid 30180419)
49. Wood A, Massarano A, Super M, Harrington R: Behavioral aspects and psychiatric findings in Noonan's syndrome. Arch Dis Child 1995;72:153-155.
50. Ghaziuddin M, Bolyard B, Alessi N: Autistic disorder in Noonan syndrome. J Intellect Disabil Res 1994;38:67-72. (Pubitemid 24045743)
51. Verhoeven W, Wingbermühle E, Egger J, Van der Burgt I, Tuinier S: Noonan syndrome: psychological and psychiatric aspects. Am J Med Genet 2008;146 A: 191-196.
52. Lee NB, Kelly L, Sharland M: Ocular manifestations of Noonan syndrome. Eye 1992;6:328-334. (Pubitemid 23055180)
53. Ascaso FJ, Del Buey MA, Huerva V, Latre B, Palomar A: Noonan's syndrome with keratoconus and optic disc coloboma. Eur J Ophthalmol 1993;3:101-103. (Pubitemid 23251768)
54. Schollen E, Matthijs G, Fryns JP: PTPN11 mutation in a young man with Noonan syndrome and retinitis pigmentosa. Genet Couns 2003;14:259. (Pubitemid 36827725)
55. Elgohary MA, Bradshaw P, Ahmad N: Anterior uveitis and congenital fibrosis of the extraocular muscles in a patient with Noonan syndrome. J Postgrad Med 2005;51:319-321. (Pubitemid 43075891)
56. Au YK, Collins WP, Patel JS, Asamoah A: Spontaneous corneal rupture in Noonan syndrome. A case report. Ophthalmic Genet 1997;18:39-41. (Pubitemid 27222913)
57. Cremers C W R J, Van der Burgt C J A M: Hearing loss in Noonan syndrome. Int J Pediatr Otorhinol 1992;23:81-84.
58. Qui WW, Yin SS, Stucker FJ: Audiologic manifestations of Noonan syndrome. Otolaryngol Head Neck Surg 1998;118:319-323. (Pubitemid 28150738)
59. Naficy S, Shepard NT, Telian SA: Multiple temporal bone anomalies associated with Noonan syndrome. Otolaryngol Head Neck Surg 1997;116:265-267. (Pubitemid 27097559)
60. Chitayat D, Hodgkinson KA, Ginsburg O, Dimmick J, Watters GV: King syndrome: a genetically heterogeneous phenotype due to congenital myopathies. Am J Med Genet 1992;43:954-956.
61. Hunter A, Pinsky L: An evaluation of the possible association of malignant hyperpyrexia with Noonan syndrome using serum creatine phosphokinase levels. J Pediatr 1975;96:412-415.
62. King JO, Denborough MA: Anestheticinduced malignant hyperpyrexia in children. J Pediatr 1973;83:37-40.
63. Rissam HS, Mittal SR, Wahi PL, Bidwai PS: Post-operative hyperpyrexia in a case of Noonan's syndrome. Indian Heart J 1982;34:180-182.
64. Steenson AJ, Torkelson RD: King's syndrome with malignant hyperthermia. Am J Dis Child 1987;141:271-273.
65. Addante RR, Breen GH: Cherubism in a patient with Noonan's syndrome. J Oral Maxillofac Surg 1996;54:210-213. (Pubitemid 26046071)
66. Betts NJ, Stewart JC, Fonseca RJ, Scott RF: Multiple central giant cell lesions in a Noonan-like phenotype. Oral Surg Oral Med Oral Pathol 1993;76:601-607. (Pubitemid 23347013)
67. Chuong R, Kaban LB, Kozakewich H, Perez-Atayde A: Central giant cell lesions of the jaws: a clinicopathologic study. J Oral Maxillofac Surg 1986;44:708-713. (Pubitemid 16054060)
68. Dunlap C, Neville B, Vickers RA, O'Neil D, Barker B: The Noonan syndrome/cherubism association. Oral Surg Oral Med Oral Pathol 1989;67:698-705. (Pubitemid 19163765)
69. Hoyer PF, Neukam FW: Cherubismus - eine osteofibröse Kiefererkrankung im Kindesalter. Klin Paediatr 1982;194:128-131. (Pubitemid 12123859)
70. Sugar AW, Ezsias A, Bloom AL, Morcos WE: Orthognathic surgery in a patient with Noonan's syndrome. J Oral Maxillofac Surg 1994;52:421-425. (Pubitemid 24119423)
71. Weldon L, Cozzi G: Multiple giant cell lesions of the jaws. J Oral Maxillofac Surg 1982;40:520-522. (Pubitemid 13232765)
72. Mangion J, Rahman N, Edkins S, Barfoot R, Nguyen T, et al: The gene for cherubism maps to chromosome 4p16.3. Am J Hum Genet 1999;65:151-157. (Pubitemid 30470459)
73. Jafarov T, Ferimazova N, Reichenberger E: Noonan-like syndrome mutations in PTPN11 in patients diagnosed with cherubism. Clin Genet 2005;68:190-191. (Pubitemid 40990635)
74. Wolvius EB, De Lange J, Smeets E E J, Van der Wal K G H, Van Den Akker HP: Noonan-like/multiple giant cell lesion syndrome: Report of a case and review of the literature. J Oral Maxillofac Surg 2006;64:1289-1292. (Pubitemid 44051766)
75. Clericuzio CL, Roberts A, Kucherlapati RS, Tworog-Dube E, Allanson JE: Communicating hydrocephalus in Noonan syndrome: A consequence of lymphatic dysplasia? Proc Greenwood Gen Ctr 2008;27:81.
76. Fryns JP: Progressive hydrocephalus in Noonan syndrome. Clin Dysmorphol 1997;6:379.
77. Henn W, Reichert H, Nienhaus Z, Zankl M, Lindinger A, et al: Progressive hydrocephalus in two members of a family with autosomal dominant Noonan phenotype. Clin Dysmorphol 1997;6:153-156. (Pubitemid 27179698)
78. Heye N, Dunne JW: Noonan's syndrome with hydrocephalus, hindbrain herniation, and upper cervical intracord cyst. J Neurol Neurosurg Psychiatry 1995;59:338-339.
79. Walter BA, Valera VA, Takahashi S, Ushiki T: The olfactory route for cerebrospinal fluid drainage into the peripheral nervous system. Neuropathol Appl Neurobiol 2006;32:388-396. (Pubitemid 44015580)
80. Ball MJ, Peiris A: Chiari (type I) malformation and syringomyelia in a patient with Noonan's syndrome. J Neurol Neurosurg Psychiatry 1982;45:753-754. (Pubitemid 12039883)
81. Holder-Espinasse M, Winter RM: Type 1 Arnold-Chiari malformation and Noonan syndrome. A new diagnostic feature. Clin Dysmorphol 2003;12:275. (Pubitemid 37267195)
82. Hughes HE, Hughes RM, Summers A, Hochhauser L: Noonan syndrome and lateral meningoceles: another link with neurofibromatosis. Proc Greenwood Genet Ctr 1987;6:159.
83. Hara T, Sasaki T, Miyauchi H, Takakura K: Noonan phenotype associated with intracerebral hemorrhage and cerebral vascular anomalies: Case report. Surg Neurol 1993;39:31-36. (Pubitemid 23053987)
84. Hinnant CA: Thromboembolic infarcts occurring after mild traumatic brain injury in a paediatric patient with Noonan's syndrome. Brain Injury 1994;8:719-727. (Pubitemid 24353194)
85. Hinnant CA: Noonan syndrome associated with thromboembolic brain infarcts and posterior circulation abnormalities. Am J Med Genet 1995;56:241-244.
86. Robertson S, Tsang B, Aftimos S: Cerebral infarction in Noonan syndrome. Am J Med Genet 1997;71:111-114. (Pubitemid 27276709)
87. Schon F, Bowler J, Baraitser M: Cerebral arteriovenous malformation in Noonan's syndrome. Postgrad Med J 1992;68:37-40.
88. Tanaka Y, Masuno M, Iwamoto H, Aida N, Ijiri R, et al: Noonan syndrome and cavernous hemangioma of the brain. Am J Med Genet 1999;82:212-214. (Pubitemid 29078806)
89. George CD, Patton MA, El Sawi M, Sharland M, Adam EJ: Abdominal ultrasound in Noonan syndrome: A study of 44 patients. Pediatr Radiol 1993;23:316-318. (Pubitemid 23256311)
90. Elsawi MM, Pryor JP, Klufio G, Barnes C, Patton MA: Genital tract function in men with Noonan syndrome. J Med Genet 1994;31:468-470. (Pubitemid 24182940)
91. Daoud MS, Dahl PR, Su WP: Noonan syndrome. Semin Dermatol 1995;14:140-144.
92. Pierini DO, Pierini AM: Keratosis pilaris atrophicans faciei (ulerythema ophryogenes): A cutaneous marker in the Noonan's syndrome. Br J Dermatol 1979;100:409-416. (Pubitemid 9251078)
93. Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, Fodale V, et al: Gain-offunction SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 2007;39:75-79. (Pubitemid 46026504)
94. Zenker M, Horn M, Wieczorek D, Allanson J, Pauli S, et al: SOS1 is the second most common Noonan gene but plays no major role in cardio-facio-cutaneous (CFC) syndrome. J Med Genet 2007;44:651-656. (Pubitemid 47584760)
95. Lohmann DR, Gillessen-Kaesbach G: Multiple cutaneous granular cell tumours in a patient with Noonan syndrome. Clin Dysmorphol 2001;19:301-302.
96. Sahn EE, Dunlavey ES, Parsons JL: Multiple cutaneous granular cell tumors in a child with possible neurofibromatosis. J Am Acad Dermatol 1997;36:327-330. (Pubitemid 27078898)
97. Witt DR, Hoyme HE, Zonana J, Manchester DK, Fryns JP, et al: Lymphedema in Noonan syndrome: Clues to pathogenesis and premature diagnosis and review of the literature. Am J Med Genet 1987;27:841-856. (Pubitemid 17151149)
98. Bloomfield FH, Hadden W, Gunn TR: Lymphatic dysplasia in a neonate with Noonan's syndrome. Pediatr Radiol 1997;27:321-323. (Pubitemid 27174305)
99. Evans DG, Lonsdale RN, Patton MA: Cutaneous lymphangioma and amegakaryocytic thrombocytopenia in Noonan syndrome. Clin Genet 1991;39:228-232.
100. Sharland M, Patton MA, Talbot S, Chitolie A, Bevan DH: Coagulation-factor deficiencies and abnormal bleeding in Noonan's syndrome. Lancet 1992;339:19-21.
101. Witt DR, McGillivray BC, Allanson JE, Hughes HE, Hathaway WE, et al: Bleeding diathesis in Noonan syndrome: a common association. Am J Med Genet 1988;31:305-317.
102. De Haan M, Van der Kamp J J P, Briet E, Dubbeldam J: Noonan syndrome: partial factor XI deficiency. Am J Med Genet 1988;29:277-282. (Pubitemid 18068250)
103. Emmerich J, Aiach M, Capron L, Fiessinger JN: Noonan's syndrome and coagulation-factor deficiencies. Lancet 1992;339:431.
104. Kitchens CS, Alexander JA: Partial deficiency of coagulation factor XI as a newly recognized feature of Noonan syndrome. J Pediatr 1983;102:224-227. (Pubitemid 13194703)
105. Massarano A, Wood A, Tait RC, Stevens R, Super M: Noonan syndrome: Coagulation and clinical aspects. Acta Paediatr 1996;85:1181-1185. (Pubitemid 26346012)
106. Singer ST, Hurst D, Addiego JE Jr: Bleeding disorders in Noonan syndrome: three case reports and review of the literature. J Pediatr Hematol Oncol 1997;19:130-134. (Pubitemid 27200555)
107. Humbert JR, Hammond KB, Hathaway WE: Trimethylaminuria: the fishodour syndrome. Lancet 1970;2:770-771.
108. Feldman KW, Ochs HD, Price TH, Wedgwood RJ: Congenital stem cell dysfunction associated with Turnerlike phenotype. J Pediatr 1976;88:979-998.
109. Sackey K, Sakati N, Aur R J A, Shebib S, Sabbah RS, Rifai S: Multiple dysmorphic features and pancytopenia: a new syndrome? Clin Genet 1985;27:606-610. (Pubitemid 15067905)
110. Attard-Montalto SP, Kingston JE, Eden T: Noonan's syndrome and acute lymphoblastic leukaemia. Med Pediatr Oncol 1994;23:391-392. (Pubitemid 24282403)
111. Johannes JM, Garcia ER, De Vaan GA, Weening RS: Noonan's syndrome in association with acute leukemia. Pediatr Hematol Oncol 1995;12:571-575.
112. Piombo M, Rosana C, Pasino M, Marasini M, Cerruti P, Comelli A: Acute lymphoblastic leukemia in Noonan syndrome: report of two cases. Med Pediatr Oncol 1993;21:454-455. (Pubitemid 23202825)
113. Roti G, La Starza R, Ballanti S, Crescenzi B, Romoli S, et al: Acute lymphoblastic leukaemia in Noonan syndrome. Br J Haematol 2006;133:448-450.
114. Bader-Meunier B, Tchernia G, Mielot F, Fontaine JL, Thomas C, et al: Occurrence of myeloproliferative disorder in patients with Noonan syndrome. J Pediatr 1997;130:885-889. (Pubitemid 27495115)
115. Fukuda M, Horibe K, Miyajima Y, Matsumoto K, Nagashima M: Spontaneous remission of juvenile chronic myelomonocytic leukemia in an infant with Noonan syndrome. J Pediatr Hematol Oncol 1997;19:177-178.
116. Kratz CP, Nathrath M, Freisinger P, Dressel P, Assmuss H-P, et al: Lethal proliferation of erythroid precursors in a neonate with a germline PTPN11 mutation. Eur J Pediatr 2006;165:182-185. (Pubitemid 43199158)
117. Kratz CP, Niemeyer CM, Castleberry RP, Cetin M, Bergstrasser E, et al: The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome. Blood 2005;15:2183-2185. (Pubitemid 41291737)
118. Jongmans M, Sistemans EA, Rikken A, Nillesen WM, Tamminga R, et al: Genotypic and phenotypic characterization of Noonan syndrome: New data and review of the literature. Am J Med Genet A 2005;134:165-170. (Pubitemid 40446212)
119. Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, et al: Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003;34:148-150. (Pubitemid 36666923)
120. Becker CE, Rosen SW, Engelman K: Pheochromocytoma and hyporesponsiveness to thyrotropin in a 46, XY male with features of Turner phenotype. Ann Intern Med 1969;70:325-333.
121. Cotton JL, Williams RG: Noonan syndrome and neuroblastoma. Arch Pediatr Adolesc Med 1995;149:1280-1281.
122. Jung A, Bechthold S, Pfluger T, Renner C, Ehrt O: Orbital rhabdomyosarcoma in Noonan syndrome. J Pediatr Hematol Oncol 2003;25:330-332. (Pubitemid 36506224)
123. Kaplan MS, Opitz JM, Gosset FR: Noonan's syndrome: A case with elevated serum alkaline phosphatase levels and malignant schwannoma of the left forearm. Am J Dis Child 1968;116:359-366.
124. Khan S, McDowell H, Upadhyaya M, Fryer A: Vaginal rhabdomyosarcoma in a patient with Noonan syndrome. J Med Genet 1995;32:743-745.
125. Lopez-Miranda B, Westra SJ, Yazdani S, Boechar MI: Noonan syndrome associated with neuroblastoma: a case report. Pediatr Radiol 1997;27:324-326. (Pubitemid 27174306)
126. Ijiri R, Tanaka Y, Keisuke K, Masuno M, Imaizumi K: A case of Noonan's syndrome with possible associated neuroblastoma. Pediatr Radiol 2000;30:432-433. (Pubitemid 30330454)
127. Chaves-Carballo E, Hayles AB: Ullrich-Turner syndrome in the male: review of the literature and report of a case with lymphocytic (Hashimoto's) thyroiditis. Mayo Clin Proc 1966;41:843-854.
128. Vesterhus P, Aarskog D: Noonan's syndrome and autoimmune thyroiditis. J Pediatr 1973;83:237-240.
129. Amoroso A, Garzia P, Vadacca M, Galluzzo S, Del Porto F, et al: The unusual association of three autoimmune diseases in a patient with Noonan syndrome. J Adol Health 2003;32:94-97. (Pubitemid 36042819)
130. Lopez-Rangel E, Malleson PN, Lirenman DS, Roa B, Wiszniewska J, Lewis ME: Systemic lupus erythematosus and other autoimmune disorders in children with Noonan syndrome. Am J Med Genet A 2006;139:239-242.
131. Ganesan V, Kirkham FJ: Noonan syndrome and Moyamoya. Pediatr Neurol 1997;16:256-258. (Pubitemid 27225438)
132. Yamashita Y, Kusaga A, Koga Y, Nagamitsu S-I, Matsuishi T: Noonan syndrome, Moyamoya-like vascular changes, and antiphospholipid antibodies. Pediatr Neurol 2004;31:364-366. (Pubitemid 39424205)
133. Achiron R, Heggesh J, Grisaru D, Goldman B, Lipitz S, et al: Noonan syndrome: A cryptic condition in early gestation. Am J Med Genet 2000;92:159-165. (Pubitemid 30228485)
134. Benacerraf BR, Greene MF, Holmes LB: The prenatal sonographic features of Noonan's syndrome. J Ultrasound Med 1989;8:59-64.
135. Donnenfeld A, Nazir MA, Sindoni F, Librizzi RJ: Prenatal sonographic documentation of cystic hygroma regression in Noonan syndrome. Am J Med Genet 1991;39:461-465.
136. Zarabi M, Mieckowski GC, Mazer J: Cystic hygroma associated with Noonan's syndrome. J Clin Ultrasound 1983;11:398-400.
137. Bawle EV, Black V: Nonimmune hydrops fetalis in Noonan's syndrome. Am J Dis Child 1986;140:758-760. (Pubitemid 16033982)